Dominant Epstein-Barr virus-specific T-cell responses are maintained during moderate and intense immunosuppressive treatment.
Daikeler
Thomas
T
Hoenger
Gideon
G
Oehri
Ineke
I
Tyndall
Alan
A
Gratwohl
Alois
A
Brander
Christian
C
Klimkait
Thomas
T
Gasser
Olivier
O
Hess
Christoph
C
D000328:Adult; D000368:Aged; D000956:Antigens, Viral / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D005260:Female; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged
D000956:Antigens, Viral; D007166:Immunosuppressive Agents